Eric Davidson Joins Mendaera’s Executive Ranks as Chief Commercial Officer

Mendaera Inc. has appointed Eric Davidson as its first chief commercial officer (CCO). He will lead the company’s commercialization efforts as it prepares to market its robotic technologies.

“We are excited to welcome Eric Davidson to the Mendaera leadership team,” Mendaera Co-Founder/CEO Josh DeFonzo said. “Eric’s proven ability to lead and grow high-performing teams, coupled with his deep expertise driving growth of disruptive technologies, will be instrumental as we pioneer a new category in healthcare robotics and prepare for significant market impact.”

Davidson joins Mendaera with more than two decades of leadership experience in medical robotics and disruptive healthcare technologies. During nine years at Intuitive Surgical, Davidson held key leadership roles in marketing and product strategy, contributing to the evolution and global success of the da Vinci Surgical System. Following Intuitive, Davidson was vice president of Sales and Marketing at Auris Health and played an important role in its acquisition for up to $5.8 billion by Johnson and Johnson (J&J). Post-acquisition, Eric helped integrate the Auris robotic technology into J&J MedTech and later served as president of its Flexible Robotics division, leading more than 500 employees and managing the P&L.

Most recently, Davidson was president and chief operating officer of Eko Health, where he advanced disruptive technologies aimed at detecting cardiovascular disease. Earlier in his career, Davidson gained foundational experience in sales and marketing at Stryker. Davidson’s career arc provides him with a unique perspective and a comprehensive understanding of building and implementing commercial operations at disruptive medical technology companies from the ground up.

As Mendaera’s CCO, Davidson will lead marketing, communications, sales, and training functions, driving the company’s go-to-market strategy to ensure the successful commercialization of the firm’s robotic platform and its global adoption across healthcare specialties and service lines.

“I am thrilled to join Mendaera and its team at this transformative time for the company and in healthcare,” Davidson stated. “Mendaera’s robotic technology will arrive as healthcare systems face worsening labor challenges and seek solutions that can support providers and enhance access to care. I look forward to helping build an organization that can deliver these crucial solutions to healthcare providers and patients.”

Davidson joins a growing commercial team including J.T. Martinez, vice president of Operations and Customer Success. Martinez has a solid background in medical robotics and previously led Support Services for Auris Health and then for J&J’s Robotics & Digital Surgery Division (after it acquired Auris Health). Martinez later became vice president of Global Customer Success for J&J’s Ethicon Division. Prior to J&J, Martinez spent nine years at Intuitive Surgical, where he led the Global Customer Care team.

Building upon additional recent growth milestones including a $73 million Series B financing round, partnership with ultrasound company EchoNous, and acquisition of Avail telepresence technology, these key leadership additions are designed to help Mendaera transform patient care with cutting-edge robotic solutions.

Mendaera is striving to digitize clinical judgment and technical expertise to improve access to care and optimize its delivery. Its platform in development combines robotics, real-time imaging, artificial intelligence, and connectivity, to enable intervention at scale. Based in Silicon Valley, Mendaera is backed by leading investors including Threshold, Lux Capital, Founders Fund, Operator Partners, and PFM Health Sciences. Mendaera’s robotic system has not been cleared by the U.S. Food and Drug Administration.